Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wai C. Wong is active.

Publication


Featured researches published by Wai C. Wong.


Bioorganic & Medicinal Chemistry | 2009

Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2

Matthew Duncton; Eugene L. Piatnitski Chekler; Reeti Katoch-Rouse; Dan Sherman; Wai C. Wong; Leon M. Smith; Joel Kawakami; Alexander S. Kiselyov; Daniel L. Milligan; Chris Balagtas; Yaron R. Hadari; Ying Wang; Sheetal Patel; Robin L. Rolster; James R. Tonra; David Surguladze; Stan Mitelman; Paul Kussie; Peter Bohlen; Jacqueline F. Doody

A series of arylphthalazine derivatives were synthesized and evaluated as antagonists of VEGF receptor II (VEGFR-2). IM-094482 57, which was prepared in two steps from commercially available starting materials, was found to be a potent inhibitor of VEGFR-2 in enzymatic, cellular and mitogenic assays (comparable activity to ZD-6474). Additionally, 57 inhibited the related receptor, VEGF receptor I (VEGFR-1), and showed excellent exposure when dosed orally to female CD-1 mice.


Synthetic Communications | 2006

Efficient Preparation of ((3‐Chloro‐2‐fluoro‐phenyl)‐[7‐methoxy‐8‐(3‐morpholin‐4‐yl‐propoxy)‐10,11‐dihydro‐5‐oxa‐2,4,11‐triaza‐dibenzo(a,d)cyclohepten‐1‐yl]‐amine) for In‐Vivo Study

Hu Liu; Leon M. Smith; Yunyu Mao; Weitao Pan; Yong-Jiang Xu; Sabina Burdzovic-Wizeman; Matthew Duncton; Wai C. Wong

Abstract An improved route for the preparation of highly functionalized 5,6‐dihydro‐pyrimido[4,5‐b][1,4]oxazepine 1a in multigram quantities was developed. This new methodology was highlighted by the proper methoxy disposition via a regioselective methylation of 2,4,5‐trihydroxy‐benzaldehyde followed by a magnesium sulfate–promoted cyclization.


Bioorganic & Medicinal Chemistry Letters | 2005

Synthesis and structure–activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors

Xiaohu Ouyang; Xiaoling Chen; Evgueni Piatnitski; Alexander S. Kiselyov; Hai-Ying He; Yunyu Mao; Vatee Pattaropong; Yang Yu; Ki Kim; John Kincaid; Leon M. Smith; Wai C. Wong; Sui Ping Lee; Daniel L. Milligan; Asra Malikzay; James Fleming; Jason Gerlak; Dhanvanthri S. Deevi; Jacqueline F. Doody; Hui-Hsien Chiang; Sheetal Patel; Ying Wang; Robin L. Rolser; Paul Kussie; Marc Labelle; M. Carolina Tuma


Bioorganic & Medicinal Chemistry Letters | 2005

Arylphthalazines: identification of a new phthalazine chemotype as inhibitors of VEGFR kinase.

Evgueni Piatnitski; Matthew Duncton; Alexander S. Kiselyov; Reeti Katoch-Rouse; Dan Sherman; Daniel L. Milligan; Chris Balagtas; Wai C. Wong; Joel Kawakami; Jacqueline F. Doody


Bioorganic & Medicinal Chemistry Letters | 2006

Arylphthalazines. Part 2: 1-(Isoquinolin-5-yl)-4-arylamino phthalazines as potent inhibitors of VEGF receptors I and II.

Matthew Duncton; Evgueni Piatnitski; Reeti Katoch-Rouse; Leon M. Smith; Alexander S. Kiselyov; Daniel L. Milligan; Chris Balagtas; Wai C. Wong; Joel Kawakami; Jacqueline F. Doody


Bioorganic & Medicinal Chemistry Letters | 2006

1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.

Weitao Pan; Hua-Quan Miao; Yong-Jiang Xu; Elizabeth Navarro; James R. Tonra; Erik Corcoran; Armin Lahiji; Paul Kussie; Alexander S. Kiselyov; Wai C. Wong; Hu Liu


Bioorganic & Medicinal Chemistry Letters | 2005

Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases.

Weitao Pan; Hu Liu; Yong-Jiang Xu; Xin Chen; Ki Kim; Daniel L. Milligan; John Columbus; Yaron R. Hadari; Paul Kussie; Wai C. Wong; Marc Labelle


Bioorganic & Medicinal Chemistry Letters | 2006

Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase

Leon M. Smith; Wai C. Wong; Alexander S. Kiselyov; Sabina Burdzovic-Wizemann; Yunyu Mao; Yong-Jiang Xu; Matthew Duncton; Ki Kim; Evgueni Piatnitski; Jacqueline F. Doody; Ying Wang; Robin L. Rosler; Daniel L. Milligan; John Columbus; Chris Balagtas; Sui Ping Lee; Andrey Konovalov; Yaron R. Hadari


Bioorganic & Medicinal Chemistry Letters | 2006

N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.

Yong-Jiang Xu; Hua-Quan Miao; Weitao Pan; Elizabeth Navarro; James R. Tonra; Stan Mitelman; Margarita Camara; Dhanvanthri S. Deevi; Alexander S. Kiselyov; Paul Kussie; Wai C. Wong; Hu Liu


Bioorganic & Medicinal Chemistry Letters | 2006

Tricyclic azepine derivatives: Pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors

Leon M. Smith; Evgueni Piatnitski; Alexander S. Kiselyov; Xiaohu Ouyang; Xiaoling Chen; Sabina Burdzovic-Wizemann; Yong-Jiang Xu; Ying Wang; Robin L. Rosler; Sheetal Patel; Hui-Hsien Chiang; Daniel L. Milligan; John Columbus; Wai C. Wong; Jacqueline F. Doody; Yaron R. Hadari

Collaboration


Dive into the Wai C. Wong's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge